(Q55064047)

16 June 2018

title

Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome (English)

1 reference

9 June 2024

author name string

E. Schweizer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604143

9 June 2024

W. G. Case

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604143

9 June 2024

F. Garcia-Espana

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604143

9 June 2024

D. J. Greenblatt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604143

9 June 2024

K. Rickels

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604143

9 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7604143

9 June 2024

publication date

1 February 1995

1 reference

16 June 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF02246214.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02246214/fulltext.html

9 June 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF02246214

9 June 2024

1 reference

9 June 2024

1 reference

16 June 2018

volume

117

1 reference

16 June 2018

issue

4

1 reference

16 June 2018

page(s)

424-429

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1007/bf02246214

exact match

0 references

cites work

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

1 reference

https://api.crossref.org/works/10.1007%2FBF02246214

A placebo-controlled study of effects of oral progesterone on performance and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246214

Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246214

Long-term Therapeutic Use of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246214

Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246214

Entry of diazepam and its major matabolite into cerebrospinal fluid.

21 January 2018

1 reference

12 December 2020

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

12 December 2020

A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms

1 reference

12 December 2020

Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration

1 reference

12 December 2020

Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorder

1 reference

12 December 2020

Anxiolytic activity of an endogenous adrenal steroid

1 reference

12 December 2020

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

1 reference

12 December 2020

Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam

1 reference

12 December 2020

Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes

1 reference

12 December 2020

Trazodone in benzodiazepine dependence

1 reference

12 December 2020

Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation

1 reference

12 December 2020

GABA-dependent modulation of the Cl- ionophore by steroids in rat brain.

1 reference

12 December 2020

Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function

1 reference

12 December 2020

Failure of buspirone to manage benzodiazepine withdrawal

1 reference

12 December 2020

Chronic benzodiazepine administration: effects in vivo and in vitro

1 reference

12 December 2020

Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency

1 reference

12 December 2020

Length of treatment with anxiolytic sedatives and response to their sudden withdrawal

1 reference

12 December 2020

Automated gas chromatographic determination of plasma alprazolam concentrations

1 reference

12 December 2020

Sleep induction by an adrenal steroid in the rat.

1 reference

12 December 2020

Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.

1 reference

12 December 2020

Benzodiazepine withdrawal symptoms and propranolol

1 reference

12 December 2020

Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers.

1 reference

12 December 2020

Advances in biochemical psychopharmacology

20

46

167

LG Miller

1990

1 reference

9 June 2024

Biological Psychiatry

25

I

778

K Rickels

1991

1 reference

9 June 2024

Identifiers

DOI

10.1007/BF02246214

1 reference

16 June 2018

Dimensions Publication ID

1015228994

0 references

1 reference

16 June 2018